I would like to know what the newly submitted non-clinical data relates. FDA were specific that the drug had to be made by Benepharm. Have they changed the process? Has that change been fully validated? Has this given rise to questions around kinectics, stability or quality of drug substance or drug product. If FDA is not satisfied that the right controls are in place, this may mean a significant delay. However, if it is just dotting i’s and crossing t’s, which FDA do all the time then the delay may be minimal. Questions have to be answered with absolute clarity or FDA will keep probing. That is my experience! I’m keen to hear a full update from the company.
- Forums
- ASX - By Stock
- Ann: PARADIGM PROVIDES IND APPLICATION UPDATE
I would like to know what the newly submitted non-clinical data...
-
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 22.5¢ | $165.2K | 713.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17828 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 11979 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12486 | 0.230 |
5 | 184444 | 0.225 |
15 | 211076 | 0.220 |
6 | 98958 | 0.215 |
9 | 260864 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 5000 | 1 |
0.245 | 32956 | 2 |
0.250 | 18443 | 2 |
0.260 | 58362 | 1 |
0.280 | 192499 | 7 |
Last trade - 11.29am 23/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
Previous Video
Next Video
SPONSORED BY The Market Online